Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fubishu Vaginal Effervescent Tablets is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Zhejiang Kangde Pharmaceutical. It is indicated for the treatment of various gynecological inflammatory conditions, including bacterial vaginosis, trichomonal vaginitis, and vulvovaginal candidiasis (fungal vaginitis). The formulation typically incorporates herbal extracts such as *Sophora flavescens* (Kushen), *Phellodendron chinense* (Huangbai), and *Cnidium monnieri* (Shechuangzi), which are recognized in TCM for their heat-clearing, dampness-drying, and antimicrobial properties. As an effervescent tablet designed for vaginal administration, the drug rapidly disintegrates upon contact with vaginal secretions, allowing the active botanical components to exert local anti-inflammatory and broad-spectrum antimicrobial effects against common vaginal pathogens.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fubishu Vaginal Effervescent Tablets.